GEOHealth Hub: Household Air Pollution and Cardio-pulmonary and Immune Function Outcomes
Bangladesh Center for Global Environmental and Occupational Health: A Study of Effects of Household Air Pollution on Cardio-pulmonary and Immune Function Outcomes Among Nonsmokers and Their Potential Prevention Avenues in Rural Bangladesh
2 other identifiers
interventional
200
1 country
1
Brief Summary
Background: The increasing effect of environmental, occupational and climate change poses serious global threat for public health. More than half of the world's population, including around 85% people in Bangladesh, are exposed to household air pollutants (HAP). Environmental consequences of climate change are among the highest. Little evidence is available on the effects HAP on cardiopulmonary outcomes in low-income populations. Same is true for occupational health and climate change. The investigators will evaluate the effects of HAP on cardio-pulmonary and markers of immune function among non-smoking individuals. The investigators will also conduct two pilot studies to explore health effects associated with working in the garments industry and that of temperature due to climate changes. Hypothesis:
- 1.Preclinical measures of cardiovascular diseases and pulmonary function are associated with exposure level of house hold air pollution (HAP) (assessed through PM2.5, CO and BC concentrations)
- 2.Stable biomarkers of immune function and inflammation are associated with exposure level of HAP.
- 3.Use of improved cook stove reduces exposure to HAP and thereby improve pre-clinical and molecular measures of cardio-pulmonary and immune functions.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Oct 2017
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
June 28, 2016
CompletedFirst Posted
Study publicly available on registry
July 6, 2016
CompletedStudy Start
First participant enrolled
October 1, 2017
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2022
CompletedFebruary 8, 2022
January 1, 2022
5.2 years
June 28, 2016
February 6, 2022
Conditions
Outcome Measures
Primary Outcomes (9)
PM2.5
The investigators will measure pre and post Changes in particulate matter \<2.5 micrometers exposure (PM2.5) through 24-hour personal monitoring
Two Years
CO
The investigators will measure pre and post Changes in carbon monoxide (CO) exposure through 24-hour personal monitors
Two Years
FEV1
The investigators will measure pre post changes in Forced Expiratory Volume in 1 second (FEV1) by spirometry
Two Years
FVC
The investigators will measure pre post changes in Forced Vital Capacity (FVC) by spirometry
Two Years
FEV1/FVC
The investigators will measure pre post changes in the ratio of Forced Expiratory Volume in 1 second and Forced Vital Capacity (FEV1/FVC) by spirometry
Two Years
Reactive hyperemia-peripheral arterial tonometry (RH-PAT) (Endothelial dysfunction)
Endothelial dysfunction will be measured by reactive hyperemia-peripheral arterial tonometry (RH-PAT) and Pre and post comparison will be done pre post intervention changes will be assessed
Two Years
Atherosclerosis [carotid intima-media thickness (cIMT)]
Atherosclerosis will be measured by ultrasound-assessed carotid intima-media thickness (cIMT) pre post intervention changes will be assessed
Two Years
Vascular stiffness [brachial artery distensibility (BAD) ]
Vascular stiffness will be measured by brachial artery distensibility (BAD) and pre post intervention changes will be compared
Two Years
Biomarkers of immune dysfunction and inflammation
Pre and post intervention changes of activation status of macrophages, dendritic cells and T-cell proliferation will be compared
Two Years
Study Arms (1)
Improved cook stove
EXPERIMENTALThe investigators will conduct a pre-post intervention study to evaluate effectiveness of improved stoves and compare outcomes after two years
Interventions
The investigators will conduct a pre-post intervention study to evaluate effectiveness of improved stoves and compare outcomes after two years
Eligibility Criteria
You may qualify if:
- \) aged between 25 and 65, 2) live in biomass using home with traditional stoves, 3) non-smoker and live with non-smokers, 4) exposed to \<5 µg/L of water arsenic,
You may not qualify if:
- \) Any immune related illness or taking any prescription medication (particularly those that suppress or enhance immune function), and 2) any clinical events of CVD or lung disease, including stroke or coronary heart disease.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- International Centre for Diarrhoeal Disease Research, Bangladeshlead
- Fogarty International Center of the National Institute of Healthcollaborator
- National Institute of Environmental Health Sciences (NIEHS)collaborator
- University of Chicagocollaborator
- York Universitycollaborator
- UChicago Research, Bangladeshcollaborator
- Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladeshcollaborator
- Bangladesh Atomic Energy commissioncollaborator
Study Sites (1)
International Centre for Diarrhoeal Disease Research, Bangladesh
Dhaka, 1212, Bangladesh
Related Publications (1)
Raqib R, Akhtar E, Ahsanul Haq M, Ahmed S, Haque F, Chowdhury MAH, Shahriar MH, Begum BA, Eunus M, Sarwar G, Parvez F, Sharker Y, Ahsan H, Yunus M. Reduction of household air pollution through clean fuel intervention and recovery of cellular immune balance. Environ Int. 2023 Sep;179:108137. doi: 10.1016/j.envint.2023.108137. Epub 2023 Aug 9.
PMID: 37579572DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Mohammad Yunus, MBBS, MSc.
International Centre for Diarrhoeal Disease Research, Bangladesh
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- PREVENTION
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
June 28, 2016
First Posted
July 6, 2016
Study Start
October 1, 2017
Primary Completion
December 1, 2022
Study Completion
December 1, 2022
Last Updated
February 8, 2022
Record last verified: 2022-01
Data Sharing
- IPD Sharing
- Will share
All data collected of the proposed study will be made fully available to any bonafide researcher. In general, the investigators will follow the data sharing plan developed and practiced by the NIH-funded grantees. Any data request by external researchers will be reviewed by the PIs and the AOC and the requested specific data will be made available to the through a secured web-based interface developed specifically for this project. In general, data will be made available six months after the manuscript reporting results from those specific sets of data are accepted for publication and all data requests will be processed within six months from the receipt of the request in writing. Any data requests with potential conflicts will be reviewed and decided by the AOC.